Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis Bone Drug Cuts Risk of Breast Cancer Return in Study
Novartis Bone Drug Cuts Risk of Breast Cancer Return in Study
Novartis Bone Drug Cuts Risk of Breast Cancer Return in Study
Submitted by
admin
on February 12, 2009 - 6:24am
Source:
Bloomberg
News Tags:
breast cancer
Novartis
Zometa
Headline:
Novartis Bone Drug Cuts Risk of Breast Cancer Return in Study
Do Not Allow Advertisers to Use My Personal information
